Andrew Tsai
Stock Analyst at Jefferies
(3.47)
Main Sectors:
Top Industries:
21 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BIIB Biogen | Initiates Coverage On: Buy | 190 | 159.88 | 18.84% | 1 | Sep 25, 2025 | |
SRPT Sarepta Therapeutics | Maintains: Buy | 40 35 | 22.64 | 54.59% | 3 | Jul 24, 2025 | |
STOK Stoke Therapeutics | Initiates Coverage On: Buy | 30 | 25.56 | 17.37% | 1 | Jul 18, 2025 | |
BBIO BridgeBio Pharma | Initiates Coverage On: Buy | 70 | 52.86 | 32.43% | 1 | Jul 14, 2025 | |
VRNA Verona Pharma | Maintains: Strong Buy | 95 110 | 106.79 | 3.01% | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 29 3 | 3.15 | -20.63% | 2 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 200 | 120.3 | 66.25% | 1 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 27 | 18.71 | 44.31% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 5 1 | n/a | n/a | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 4 13 | 2.32 | 460.34% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 28.54 | 22.63% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 21 | n/a | n/a | 1 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 33 | 6.9 | 378.26% | 1 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 1 15 | 3.65 | 310.96% | 2 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 3 | 1.41 | 112.77% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 320 30 | 4.14 | 624.64% | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 70 | n/a | n/a | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | 5.23 | 416.25% | 1 | Sep 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 16 23 | 39.61 | -41.93% | 1 | Jun 1, 2020 |